Symetis receives CE Mark approval for transfemoral transcatheter aortic heart valve system ACURATE neo™,

First Page		Document Content
Date: 2014-10-22 02:50:49 Percutaneous aortic valve replacement Torso Medicine Human body Edwards Lifesciences Aortic valve Tavi Cardiology Cardiac surgery Aorta John G. Webb		Symetis receives CE Mark approval for transfemoral transcatheter aortic heart valve system ACURATE neo™, Add to Reading List Source URL: www.biomedvc.com Download Document from Source Website File Size: 198,45 KB Share Document on Facebook

	Glossary antibiotic: A drug that can kill or inhibit the growth of bacteria. Antibiotics are not effective against viruses. aorta: The largest artery in the human body. It originates in the left ventricle of the heart an DocID: 1v8nU - View Document
	20 JAAR \| 20 GEBOUWEN FIETSTOCHT DOOR LEIDSCHE RIJN ARCHITECTUURCENTRUM AORTA 1 DAFNE SCHIPPERSBRUG NEXT ARCHITECTS 2017 DocID: 1uwcH - View Document
	High Temporal Resolution Finite Element Simulations of the Aorta for Thoracic Impedance Cardiography Mark Ulbrich*, Piotr Paluchowski, Jens Muehlsteff and Steffen Leonhardt Aachen, Germany High Temporal Resolution Finite DocID: 1ugA2 - View Document
	RESEARCH One-stage endovascular management of penetrating thoracic aorta ulcer accompanied by multisupraarch branches stenosis DocID: 1tWfc - View Document
	Symetis receives CE Mark approval for transfemoral transcatheter aortic heart valve system ACURATE neo™, DocID: 1rff4 - View Document